• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Interstitial Lung Disease

Interstitial lung disease is a set of diseases that can cause inflammation and scarring (fibrosis) of the lungs. They can make it hard to breathe. Over time, the harm may get worse.

In many chronic disease populations the disadvantage of a neighborhood is associated with negative health outcomes. We examined data from 6683 patients with fibrotic interstitial lung disease (fILD) who were prospectively enrolled in the Simmons and Pulmonary Fibrosis Foundation (PFF) registry and eight canadian pacific acute myeloid leukemia registry sites of the canadian pacific Mesothelioma Registry for Pulmonary Fibrosis (CARE-PF). The findings show that living in a neighbourhood with more disadvantage is associated higher mortality and lower odds for lung transplantation in Canada but not in the U.S., where patients have greater access to healthcare services under an universal health system.

Signs and symptoms

The term"interstitial lung diseases" (ILD) refers to a class of diseases that cause scarring in the lungs. This scarring makes it harder for the lungs to receive oxygen into the body. This damage is permanent and will get worse with time. The most common signs are a dry cough and shortness of breath. a dry cough. Other symptoms include chest pain, fatigue and occasionally weight loss. ILD can be caused by a variety of conditions, and the symptoms vary from one person to the next. ILD symptoms may manifest gradually or swiftly.

If you are experiencing any of these symptoms, canadian Pacific Mesothelioma it is important to talk to your doctor. You should also get your regular flu shots and pneumococcal. Pneumococcal infection can lead to serious problems such as meningitis, or pneumonia.

ILD symptoms can be similar to those of other medical conditions. It is important to inform your doctor of all possible causes before making a diagnoses. Your doctor will review the circumstances of your illness and conduct a physical examination. A chest X ray and blood tests may help determine the reason for your symptoms. A pulmonary function test can determine how well your lungs function by taking note of the amount of air you exhale from your lungs. A CT scan of the lungs can also be helpful. It can detect fibrosis and help your doctor diagnose the kind of ILD you suffer from.

Diagnosis

ILD is a term that refers to more than 100 lung diseases that cause inflammation and scarring (pulmonary fibrosis). These conditions can make breathing difficult and aren't cureable. ILDs can range from mild to life-threatening. Idiopathic Pulmonary Fibrious Disease which is the most prevalent ILD, has a poor prospects of recovery.

Idiopathic Pulmonary Fibrosis is a progressive, chronic disease that is manifested by breathlessness and dry cough that does not go away. It is typically seen in middle-aged and older adults. It is difficult to determine, as the symptoms are similar to other conditions like chronic obstructive pulmonary disease and heart failure.

To determine the presence of ILD to diagnose it, your doctor will prescribe chest Xrays or a CT scan to look more closely at your lungs. Your doctor may also order a pulmonary function test in order to assess the lung capacity, which could have diminished due to ILD. In more serious cases, and to identify a specific type of ILD, your doctor may require the bronchoscopy procedure or a lung biopsy.

These procedures involve the removal of an insignificant piece of tissue from your lungs to allow it to be examined under a microscope. This information is used by your doctor to determine the most appropriate treatment for you. This will usually focus on preventing any further damage to your lungs while also addressing symptoms and helping you remain active.

Treatment

Interstitial Fibrosis is a group of more than 200 lung diseases that are defined by scarring and inflammation. It causes difficulty for the lung to absorb oxygen. The condition could be life-threatening. Treatment can improve breathing and slow down the disease's progression.

Scarring and inflammation can be caused by many things such as smoking or exposure to industrial toxic substances. Other causes include air pollution, infections and medications as well as auto-immune diseases such as the rheumatoid joint or systemic sclerosis.

The shortness of breath is common among those suffering from fibrosing lung disease. It is most noticeable when they breathe in. They may also develop dry coughs or chest pain. Tests, like blood tests or imaging tests will help to determine the cause. People who have advanced or severe forms of the disease may benefit from treatment, which helps to reduce the symptoms and Canadian Pacific Kidney Cancer prevent further scarring.

Patients suffering from fibrosing ILD who reside in areas that have a greater disadvantage in the neighborhood in the United States are at higher risk of dying and are less likely to receive a lung transplant as a final stage therapy. These disparities, however do not exist in the canadian pacific myelodysplastic syndrome group. This could be due to differences in accessing care. In models adjusting for gender, age at diagnosis, smoking history, White or non-White race as well as baseline FVC and DLCO, and connective tissue disease type, living in communities with higher disadvantage was associated with lower baseline DLCO however, not with the rate of DlCO decline over time.